Alex Martinez

607 total citations
8 papers, 497 citations indexed

About

Alex Martinez is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, Alex Martinez has authored 8 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 4 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in Alex Martinez's work include Cannabis and Cannabinoid Research (4 papers), Neuroscience and Neuropharmacology Research (4 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Alex Martinez is often cited by papers focused on Cannabis and Cannabinoid Research (4 papers), Neuroscience and Neuropharmacology Research (4 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Alex Martinez collaborates with scholars based in United States, Italy and Germany. Alex Martinez's co-authors include Andrea Giuffrida, Alexandre Seillier, James L. Roberts, Teresa Macheda, Wouter Koek, David A. Price, Randy Strong, Beat Lutz, Elizabeth Fernández and Giovanni Marsicano and has published in prestigious journals such as PLoS ONE, Neuropsychopharmacology and European Journal of Neuroscience.

In The Last Decade

Alex Martinez

8 papers receiving 490 citations

Peers

Alex Martinez
Alex Martinez
Citations per year, relative to Alex Martinez Alex Martinez (= 1×) peers Francisco Espejo‐Porras

Countries citing papers authored by Alex Martinez

Since Specialization
Citations

This map shows the geographic impact of Alex Martinez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Martinez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Martinez more than expected).

Fields of papers citing papers by Alex Martinez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Martinez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Martinez. The network helps show where Alex Martinez may publish in the future.

Co-authorship network of co-authors of Alex Martinez

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Martinez. A scholar is included among the top collaborators of Alex Martinez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Martinez. Alex Martinez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Seillier, Alexandre, Alex Martinez, & Andrea Giuffrida. (2020). Differential effects of Δ9-tetrahydrocannabinol dosing on correlates of schizophrenia in the sub-chronic PCP rat model. PLoS ONE. 15(3). e0230238–e0230238. 15 indexed citations
2.
Martinez, Alex, Maria Grazia Morgese, Augusta Pisanu, et al.. (2014). Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats. Neurobiology of Disease. 74. 295–304. 52 indexed citations
3.
Seillier, Alexandre, Alex Martinez, & Andrea Giuffrida. (2013). Phencyclidine-Induced Social Withdrawal Results from Deficient Stimulation of Cannabinoid CB1 Receptors: Implications for Schizophrenia. Neuropsychopharmacology. 38(9). 1816–1824. 60 indexed citations
4.
Cheng, Benxu, et al.. (2012). Retinoic acid protects against proteasome inhibition associated cell death in SH-SY5Y cells via the AKT pathway. Neurochemistry International. 62(1). 31–42. 48 indexed citations
5.
Paquette, Melanie, Alex Martinez, Teresa Macheda, et al.. (2012). Anti‐dyskinetic mechanisms of amantadine and dextromethorphan in the 6‐OHDA rat model of Parkinson’s disease: role of NMDA vs. 5‐HT1A receptors. European Journal of Neuroscience. 36(9). 3224–3234. 44 indexed citations
6.
Cheng, Benxu, et al.. (2011). Insulin-like growth factor-I mediates neuroprotection in proteasome inhibition-induced cytotoxicity in SH-SY5Y cells. Molecular and Cellular Neuroscience. 47(3). 181–190. 36 indexed citations
7.
Martinez, Alex, Teresa Macheda, Maria Grazia Morgese, Luigia Trabace, & Andrea Giuffrida. (2011). The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats. Neuroscience Research. 72(3). 236–242. 43 indexed citations
8.
Price, David A., Alex Martinez, Alexandre Seillier, et al.. (2009). WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease. European Journal of Neuroscience. 29(11). 2177–2186. 199 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026